108 related articles for article (PubMed ID: 20802307)
1. Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent.
Pisu C; Pira L; Pani L
Behav Pharmacol; 2010 Oct; 21(7):649-53. PubMed ID: 20802307
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
Gupta D; Radhakrishnan M; Kurhe Y
Eur J Pharmacol; 2014 Nov; 742():94-101. PubMed ID: 25199966
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Nogueira CW; Zeni G
Behav Brain Res; 2009 Dec; 205(2):511-7. PubMed ID: 19683021
[TBL] [Abstract][Full Text] [Related]
7. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
8. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
Fogaça MV; Reis FM; Campos AC; Guimarães FS
Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
[TBL] [Abstract][Full Text] [Related]
9. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.
Cross AJ; Widzowski D; Maciag C; Zacco A; Hudzik T; Liu J; Nyberg S; Wood MW
Br J Pharmacol; 2016 Jan; 173(1):155-66. PubMed ID: 26436896
[TBL] [Abstract][Full Text] [Related]
11. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
Briones-Aranda A; López-Rubalcava C; Picazo O
Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
[TBL] [Abstract][Full Text] [Related]
12. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.
Moreira FA; Aguiar DC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1466-71. PubMed ID: 16876926
[TBL] [Abstract][Full Text] [Related]
14. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
18. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
[TBL] [Abstract][Full Text] [Related]
19. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Roychoudhury M; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
[TBL] [Abstract][Full Text] [Related]
20. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]